TABLE 4.

Correlations Between SCCAI, 6-Point Mayo, and Patient-Driven Assessment

Indices	Rho; P	Sensitivity; Specificity (%)a
Full survey population (n = 282)
6-point Mayo and SCCAI	0.71; <0.0001	89; 67
6-point Mayo and patient-driven assessment	0.65; <0.0001	83; 72
SCCAI and patient-driven assessment	0.66; <0.0001	76; 87
Exposure to immunosuppressant therapy (n = 152)
6-point Mayo and SCCAI	0.73; <0.0001	91; 71
6-point Mayo and patient-driven assessment	0.67; <0.0001	82; 73
SCCAI and patient-driven assessment	0.66; <0.0001	73; 86
Validation cohort (n = 59)
6-point Mayo and SCCAI	0.74; <0.0001	95; 79
6-point Mayo and patient-driven assessment	0.63; <0.0001	90; 72
SCCAI and patient-driven assessment	0.74; <0.0001	85; 72
Pan-colitis cohort (n = 45)
6-point Mayo and SCCAI	0.76; <0.0001	—
6-point Mayo and patient-driven assessment	0.60; <0.0001	—
SCCAI and patient-driven assessment	0.71; <0.0001	—
Left-sided colitis cohort (n = 14)
6-point Mayo and SCCAI	0.64; 0.01	—
6-point Mayo and patient-driven assessment	0.65; 0.01	—
SCCAI and patient-driven assessment	0.66; 0.01	—

^aCalculated using 6-point Mayo remission <1.5 and SCCAI remission <2.5.